Company intelligence / Profile preview

Boston Scientific Corporation

Marlborough, Massachusetts, USAbostonscientific.com ↗

Ownership: Public · BSX
Employees: ~27000
Development stage: Commercial

Overview

Boston Scientific is a global medical technology leader with over 13,000 products that help clinicians treat more than 24 million patients each year. The company has 135 active clinical trials underway.

Therapeutic areas: GastroenterologyCardiovascularMen's HealthWomen's HealthNeurology
Modalities: Medical devices for less invasive surgical procedures
Industry: Surgical Medical Devices

Drug pipeline

2 assets

uridine triacetate

Commercial

Indications: Drug intoxication, Hereditary orotic aciduria

1 more asset in the full pipeline.

Request access →

Financials

Market cap: $66.8B
Total revenue: $5.4B
Enterprise value: $78.9B

Beyond the preview

Go deeper on Boston Scientific Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Boston Scientific Corporation.

Explore the full profile